Pediatric Phase 1/Pilot Consortium (Limited Competition UM1)

The summary for the Pediatric Phase 1/Pilot Consortium (Limited Competition UM1) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Pediatric Phase 1/Pilot Consortium (Limited Competition UM1): The purpose of this Funding opportunity Announcement (FOA) is to continue the NCIs program for Pediatric Phase 1/Pilot Consortium. The function of the Consortium is to conduct Phase 1 and pilot studies in children with cancer so that new agents can be introduced into the pediatric oncology setting in a timely manner. The Consortium's ability to quickly conduct first in children studies is critical to NCIs overall clinical research program for children with cancer. To accomplish the objectives of the FOA, a strong multi-institutional, multi-disciplinary research team is needed that can rapidly and efficiently design and conduct Phase 1 and pilot clinical trials and that is experienced in doing so within the ethical constraints applicable to research involving children. The ultimate purpose for supporting the Pediatric Phase 1/Pilot Consortium is to improve therapy outcomes for children with cancer.

Federal Grant Title:	Pediatric Phase 1/Pilot Consortium (Limited Competition UM1)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Education Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-CA-12-502
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.395
CFDA Descriptions:	Cancer Treatment Research
Current Application Deadline:	Mar 20, 2012
Original Application Deadline:	Mar 20, 2012
Posted Date:	January 5th, 2012
Creation Date:	Jan 05, 2012
Archive Date:	Apr 20, 2012
Total Program Funding:	$3,470,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:	1
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: The eligibility to apply in response to this FOA is limited to the current recipient of the Children's Oncology Group Phase 1/Pilot Consortium award.
Grant Announcement Contact: NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • Specialized Programs of Research Excellence (SPOREs) in Cancer Health Disparities and Mino...; • Cancer Adoptive Cellular Therapy Network (Can-ACT) for Pediatric Cancers (UG3/UH3 Clinical...; • Single Source: Pediatric Early Phase Clinical Trials Network (PEP-CTN; UM1 Clinical Trial ...; • Assay development and screening for discovery of chemical probes, drugs or immunomodulator...; • Next Generation Chemistry Centers for Fusion Oncoproteins (UM1 Clinical Trial Not Allowed); • Breast and Prostate Cancer Data Quality and Patterns of Care Study; • Consortium Therapeutic Studies of Primary Central Nervous System Malignancies in Adults; • National Cooperative Drug Discovery Groups for Cancer
More Grants from the National Institutes of Health: • SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies...; • Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Al...; • Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional); • Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial No...; • Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimenta...